Same-day test and treat for early detection and treatment of cervical cancer in LMICs

Abstract

In 2020, 604 000 women were diagnosed with and 342 000 women died of cervical cancer, mostly in low-income and middle-income countries (LMICs),1 making cervical cancer a public health problem in these settings. WHO recommends a 90–70–90 strategy for the elimination of cervical cancer by 2030: 90% of girls to be fully vaccinated with the human papillomavirus (HPV) vaccine by age 15 years; 70% of women screened with an HPV DNA test or other high-performance test by age 35 years, and again by age 45 years; 90% of women with cervical pre-cancer treated; and 90% of women with invasive cancer managed.